Paper32112136
Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial.
Liu S and 8 others. Eur J Nutr, 2020. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial. Papers, record 32112136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32112136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Probiotics | Major topic |
| Dysbiosis | |
| Feces | |
| Humans | |
| Male | |
| Renal Dialysis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2017ZDXM-SF-057 | Shannxi Provincial Science and Technology Foundation | PubMed | ||
| 81570670 | National Natural Science Foundation of China | PubMed |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT06825117 | PRObiotics for KIdney Transplantation | Background | ClinicalTrials.gov | |
| NCT06891105 | Effect of Probiotic and Synbiotic Administration on Nutritional Status in Hemodialysis Patients | Background | ClinicalTrials.gov | |
| NCT07531186 | Probiotic and Synbiotic Supplements in Hemodialysis Patients | Results | ClinicalTrials.gov | |
| NCT07694791 | Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients | Background | ClinicalTrials.gov |
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17115046 | Microbial translocation is a cause of systemic immune activation in chronic HIV infection. | Nat Med | 2006 | https://conductscience.org/library/papers/17115046 | PubMed |
| 2 | 26074694 | Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26074694 | PubMed |
| 3 | 21567467 | p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. | J Clin Lab Anal | 2011 | https://conductscience.org/library/papers/21567467 | PubMed |
| 4 | 25531673 | Uremic toxins and their effects on multiple organ systems. | Nephron Clin Pract | 2014 | https://conductscience.org/library/papers/25531673 | PubMed |
| 5 | 25147806 | Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25147806 | PubMed |
| 6 | 22012132 | High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. | Kidney Int | 2012 | https://conductscience.org/library/papers/22012132 | PubMed |
| 7 | 13610897 | Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. | J Biol Chem | 1959 | https://conductscience.org/library/papers/13610897 | PubMed |
| 8 | 24994892 | Galacto-oligosaccharides attenuate renal injury with microbiota modification. | Physiol Rep | 2014 | https://conductscience.org/library/papers/24994892 | PubMed |
| 9 | 14633143 | Evidence for impaired assimilation of protein in chronic renal failure. | Kidney Int | 2003 | https://conductscience.org/library/papers/14633143 | PubMed |
| 10 | 12612972 | Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. | Am J Kidney Dis | 2003 | https://conductscience.org/library/papers/12612972 | PubMed |
| 11 | 26761495 | Screening of Bacteriocin-producing Enterococcus faecalis Strains for Antagonistic Activities against Clostridium perfringens. | Korean J Food Sci Anim Resour | 2014 | https://conductscience.org/library/papers/26761495 | PubMed |
| 12 | 21315470 | Probiotic assessment of Enterococcus faecalis CP58 isolated from human gut. | Int J Food Microbiol | 2011 | https://conductscience.org/library/papers/21315470 | PubMed |
| 13 | 24059921 | Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. | Future Microbiol | 2013 | https://conductscience.org/library/papers/24059921 | PubMed |
| 14 | 29216305 | Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro. | PLoS One | 2017 | https://conductscience.org/library/papers/29216305 | PubMed |
| 15 | 19946322 | Uremic toxins originating from colonic microbial metabolism. | Kidney Int Suppl | 2009 | https://conductscience.org/library/papers/19946322 | PubMed |
| 16 | 8504064 | Insulin mediators and the mechanism of insulin action. | Adv Pharmacol | 1993 | https://conductscience.org/library/papers/8504064 | PubMed |
| 17 | 25145928 | The cardiovascular effect of the uremic solute indole-3 acetic acid. | J Am Soc Nephrol | 2015 | https://conductscience.org/library/papers/25145928 | PubMed |
| 18 | 20140211 | Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. | PLoS One | 2010 | https://conductscience.org/library/papers/20140211 | PubMed |
| 19 | 8893154 | Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. | Nephron | 1996 | https://conductscience.org/library/papers/8893154 | PubMed |
| 20 | 8857659 | Salivary factors in children and adolescents with insulin-dependent diabetes mellitus. | Pediatr Dent | 1996 | https://conductscience.org/library/papers/8857659 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42885316 | Gut microbiota in patients receiving dialysis: Mechanisms, complications and the road to personalized microbiome‑based care (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42885316 | PubMed |
| 42824281 | Clinical value of probiotics as adjunctive therapy for diabetic nephropathy: a meta-analysis and trial sequential analysis. | Front Nutr | 2026 | https://conductscience.org/library/papers/42824281 | PubMed |
| 42729188 | Alterations in gut microbiota among maintenance hemodialysis patients with CKD-associated pruritus: a cross-sectional comparative study of two cohorts. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42729188 | PubMed |
| 42573887 | Modulating the gut-joint axis: Bifidobacterium longum subsp. infantis B8762 is associated with selective gut microbial and metabolic alterations in knee osteoarthritis. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42573887 | PubMed |
| 42074989 | Impact of Probiotics, Prebiotics and Synbiotics Supplementation in Chronic Kidney Disease: A Comprehensive Review of Clinical Trials. | Nutrients | 2026 | https://conductscience.org/library/papers/42074989 | PubMed |
| 41872650 | Effect of probiotic and synbiotic administration on the nutritional status of hemodialysis patients: a randomized-controlled trial. | Int Urol Nephrol | 2026 | https://conductscience.org/library/papers/41872650 | PubMed |
| 41000396 | Gut microbiota therapy for chronic kidney disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41000396 | PubMed |
| 40799824 | The effects of Shenkang suppository on kidney function and gut microbiota in nondialysis patients with chronic kidney disease stages 3-4: A randomized controlled trial. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40799824 | PubMed |
| 40735439 | Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40735439 | PubMed |
| 40607345 | Multi-omics analysis reveals the efficacy of two probiotic strains in managing feline chronic kidney disease through gut microbiome and host metabolome. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40607345 | PubMed |
| 40351408 | Gut microbiome dynamics of patients on dialysis: implications for complications and treatment. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40351408 | PubMed |
| 40273556 | Sex differences in the association between long-term ambient particulate air pollution and the intestinal microbiome composition of children. | Environ Int | 2025 | https://conductscience.org/library/papers/40273556 | PubMed |
| 40219004 | Impact of Gut Microbiome Modulation on Uremic Toxin Reduction in Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. | Nutrients | 2025 | https://conductscience.org/library/papers/40219004 | PubMed |
| 40211390 | Characterization of gut microbiota and metabolites in renal transplant recipients during COVID-19 and prediction of one-year allograft function. | J Transl Med | 2025 | https://conductscience.org/library/papers/40211390 | PubMed |
| 40080091 | The role of the intestinal microbiome in cognitive decline in patients with kidney disease. | Nephrol Dial Transplant | 2025 | https://conductscience.org/library/papers/40080091 | PubMed |
| 40067377 | Dietary Intake and Gut Microbiome in CKD. | Clin J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/40067377 | PubMed |
| 39769292 | The Gut-Heart Axis: Effects of Intestinal Microbiome Modulation on Cardiovascular Disease-Ready for Therapeutic Interventions? | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769292 | PubMed |
| 39668321 | Gut Dysbiosis and Probiotic Therapy in Chronic Kidney Disease: A Comprehensive Review. | Probiotics Antimicrob Proteins | 2025 | https://conductscience.org/library/papers/39668321 | PubMed |
| 39126043 | Pathogenesis of Sarcopenia in Chronic Kidney Disease-The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39126043 | PubMed |
| 38787079 | A Historical Perspective on Uremia and Uremic Toxins. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38787079 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32112136
GET https://conductscience.org/api/papers/v1/32112136/references?page=2